These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35906015)

  • 21. Self-affirmation increases acceptance of information on COVID-19 vaccines and promotes vaccination intention.
    Li S; Xia Y; Zhao W; Miao X; Xu Q
    J Behav Med; 2023 Apr; 46(1-2):303-310. PubMed ID: 35133549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021.
    Burger R; Köhler T; Golos AM; Buttenheim AM; English R; Tameris M; Maughan-Brown B
    BMC Public Health; 2022 Mar; 22(1):422. PubMed ID: 35236319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey on COVID-19 vaccine acceptance and concern among Malaysians.
    Syed Alwi SAR; Rafidah E; Zurraini A; Juslina O; Brohi IB; Lukas S
    BMC Public Health; 2021 Jun; 21(1):1129. PubMed ID: 34118897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responses to persuasive messages encouraging professional help seeking for depression: comparison between individuals with and without psychological distress.
    Suka M; Yamauchi T; Yanagisawa H
    Environ Health Prev Med; 2019 May; 24(1):29. PubMed ID: 31068125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Countering Antivax Misinformation via Social Media: Message-Testing Randomized Experiment for Human Papillomavirus Vaccination Uptake.
    Kim SJ; Schiffelbein JE; Imset I; Olson AL
    J Med Internet Res; 2022 Nov; 24(11):e37559. PubMed ID: 36422887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addressing message fatigue for encouraging COVID-19 vaccination.
    Okuhara T; Okada H; Kiuchi T
    J Commun Healthc; 2023 Oct; 16(3):298-303. PubMed ID: 37115094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 vaccine hesitancy and its associated factors in Malaysia.
    Lee KW; Gew LT; Siau CS; Peh SC; Chia YC; Yacob S; Chan NN; Seow VK; Ooi PB
    PLoS One; 2022; 17(9):e0266925. PubMed ID: 36048822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Communicating about COVID-19 vaccine development and safety.
    Thorpe A; Fagerlin A; Butler J; Stevens V; Drews FA; Shoemaker H; Riddoch MS; Scherer LD
    PLoS One; 2022; 17(8):e0272426. PubMed ID: 35930557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of side-effect risk framing strategies on COVID-19 vaccine intentions: a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Elife; 2022 Aug; 11():. PubMed ID: 35971757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving COVID-19 vaccine uptake: a message co-design process for a national mHealth intervention in Colombia.
    Aya Pastrana N; Agudelo-Londoño S; Franco-Suarez O; Otero Machuca J; Guzman-Tordecilla DN; López Sánchez MC; Rodriguez-Patarroyo M; Rivera-Sánchez CA; Castro-Barbudo D; Trujillo AJ; Maniar V; Vecino-Ortiz AI
    Glob Health Action; 2023 Dec; 16(1):2242670. PubMed ID: 37643136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of persuasive messages on National Health Service Organ Donor Registrations: a pragmatic quasi-randomised controlled trial with one million UK road taxpayers.
    Sallis A; Harper H; Sanders M
    Trials; 2018 Sep; 19(1):513. PubMed ID: 30241564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing parents' hesitancy to vaccinate their children aged 5-11 years old against COVID-19: results from a cross-sectional study in Malaysia.
    Marzo RR; Chakraborty R; Soh SY; Thew HZ; Chong C; Siau CS; Abdul Wahab KB; Binti Ariffin IA; Chauhan S; Brackstone K; Padhi BK; Heidler P
    Front Public Health; 2023; 11():1091015. PubMed ID: 37261237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Ashworth M; Thunström L; Cherry TL; Newbold SC; Finnoff DC
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34315824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "How" Versus "Why" Messaging to Increase Uptake of Booster Vaccination Against COVID-19: Results of a Pragmatic Randomized Trial.
    Haff N; Choudhry NK; Bhatkhande G; Keller PA; Robertson T; Oran R; Horn D; Crum KL; Oduol T; Hanken K; Lauffenburger JC
    J Gen Intern Med; 2024 Mar; 39(4):611-618. PubMed ID: 37932539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Bokemper SE; Gerber AS; Omer SB; Huber GA
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.